Yousif Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-42,766
Closed -$189K 1912
2024
Q4
$189K Sell
42,766
-2,388
-5% -$9.69K ﹤0.01% 1837
2024
Q3
$186K Buy
45,154
+375
+0.8% +$2.02K ﹤0.01% 1869
2024
Q2
$292K Sell
44,779
-5,870
-12% -$41.5K ﹤0.01% 1698
2024
Q1
$441K Sell
50,649
-5,749
-10% -$69.8K ﹤0.01% 1570
2023
Q4
$645K Sell
56,398
-305
-0.5% -$3.02K 0.01% 1431
2023
Q3
$546K Sell
56,703
-3,414
-6% -$33.5K 0.01% 1440
2023
Q2
$640K Sell
60,117
-4,680
-7% -$50.3K 0.01% 1384
2023
Q1
$682K Sell
64,797
-15,530
-19% -$174K 0.01% 1335
2022
Q4
$995K Sell
80,327
-23,105
-22% -$262K 0.01% 1156
2022
Q3
$1.07M Sell
103,432
-16,365
-14% -$186K 0.02% 1154
2022
Q2
$1.38M Buy
+119,797
New +$1.41M 0.02% 1046

Other funds holding IRWD

Yousif Capital Management's IRWD Position: Q1 2025 in Review

Yousif Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 42,766 shares — an estimated $189K sold.

Yousif Capital Management first reported a position in IRWD in Q2 2022 and held it in 11 quarters. The position peaked at $1.38M in Q2 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Yousif Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Yousif Capital Management sold 42,766 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $189K.
  • Yousif Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Yousif Capital Management's Ironwood Pharmaceuticals position peaked at $1.38M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Yousif Capital Management's 13F filing for Q1 2025, filed 14 Apr 2025.